Rwanda FDA iramenyesha ko imiti ikurikira itujuje ibipimo by’ubuziranenge yagaragaye mu Karere ka Afurika y’Iburasirazuba, itigeze yinjira mu gihugu, bityo ikaba itari ku isoko ry’u Rwanda:
1.Paracetamol 1000 mg/100 ml iterwa mu rushinge icuruzwa ku mazina akurikira:
•Lumidol (ifite Nº: CM4594007, CM4594008, na CM4594009)
•Blink (ifite Nº: CS4594004, CS4594005)
•Paragen (ifite Nº: K4290027)
2.Augmentin 1g y’ibinini (ifite Nº: EU7C, SGS2) na Augmentin 625mg (ifite Nº: 8X3K)
————————————
@RwandaFDA reassures the general public that the following substandard and falsified medicines, identified in the East African region, were not imported into Rwanda and are therefore not available on the Rwandan market:
1.Paracetamol 1000 mg/100 ml injections under the following brand names:
•Lumidol (CM4594007, CM4594008, CM4594009)
•Blink (CS4594004, CS4594005)
•Paragen (K4290027)
2.Augmentin 1g tablets (EU7C, SGS2) and Augmentin 625mg tablets (8X3K)
Muri aka kanya ku Rwibutso rwa Jenoside rwa Kigali (@Kigali_Memorial ), abakozi b’Ikigo gishinzwe Kugenzura Ibiribwa n’Imiti mu Rwanda (@RwandaFDA), bari mu gikorwa cyo Kwibuka ku nshuro ya 31 Jenoside yakorewe Abatutsi mu 1994.
#Kwibuka31
Rwanda FDA has attained @WHO Maturity Level 3 for the regulation of medicines and vaccines (non-producing).
Rwanda joins an elite group of 18 regulatory authorities worldwide and becoming one of the first 8 in Africa to reach this milestone.
Check the list here: https://t.co/wcQ1hBNH16
________________________
Rwanda FDA yashyizwe ku Rwego rwa Gatatu (ML3) mu kugenzura ubuziranenge bw’imiti n’inkingo.
Ibi byatumye U Rwanda rwinjira mu itsinda ry’ibihugu cumi n’umunani(18) bimaze kugera kuri uru Rwego rwa Gatatu (ML3) ku Isi, rukaba ubu ruri mu bihugu umunani (8) bya Afurika.
Reba ibindi bihugu hano: https://t.co/wcQ1hBNH16
Rwanda FDA is hosting the @WHO Regulatory System Strengthening team for a two-day mission to complete the WHO Benchmarking assessment for Maturity Level 3 of the Global Benchmarking Tool. This is an important milestone in Rwanda’s journey toward global recognition of the Rwanda FDA as a competent authority meeting international standards for healthcare product regulation.